Healthcare provider profile · identity verified

Ellen Fan, MD

Family Practice · INDIANAPOLIS, IN · NPI 1871797134

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	636	193
Amlodipine Besylate	Amlodipine Besylate	491	145
Losartan Potassium	Losartan Potassium	334	93
Albuterol Sulfate Hfa	Albuterol Sulfate	310	80
Gabapentin	Gabapentin	276	72
Lisinopril	Lisinopril	216	68
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	210	29
Metoprolol Succinate	Metoprolol Succinate	187	52
Fluticasone Propionate	Fluticasone Propionate	171	56
Levothyroxine Sodium	Levothyroxine Sodium	170	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	168	28
Ozempic	Semaglutide	167	28
Hydrochlorothiazide	Hydrochlorothiazide	155	45
Omeprazole	Omeprazole	143	47
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	142	40
Pantoprazole Sodium	Pantoprazole Sodium	123	45
Carvedilol	Carvedilol	112	36
Jardiance	Empagliflozin	108	35
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	104	25
Duloxetine Hcl	Duloxetine Hcl	95	21
Furosemide	Furosemide	93	31
Tamsulosin Hcl	Tamsulosin Hcl	93	24
Metformin Hcl	Metformin Hcl	92	29
Pregabalin	Pregabalin	90	20
Ventolin Hfa	Albuterol Sulfate	90	27
Trulicity	Dulaglutide	82	17
Chlorthalidone	Chlorthalidone	78	26
Trazodone Hcl	Trazodone Hcl	77	24
Metoprolol Tartrate	Metoprolol Tartrate	70	17
Sertraline Hcl	Sertraline Hcl	70	19
Ibuprofen	Ibuprofen	68	23
Potassium Chloride	Potassium Chloride	64	23
Pravastatin Sodium	Pravastatin Sodium	61	15
Eliquis	Apixaban	60	18
Spiriva Handihaler	Tiotropium Bromide	60	14
Metformin Hcl Er	Metformin Hcl	57	21
Spironolactone	Spironolactone	57	19
Torsemide	Torsemide	55	15
Mirtazapine	Mirtazapine	53	21
Alendronate Sodium	Alendronate Sodium	52	15
Diclofenac Sodium	Diclofenac Sodium	51	26
Triamcinolone Acetonide	Triamcinolone Acetonide	51	26
Clopidogrel	Clopidogrel Bisulfate	50	15
Januvia	Sitagliptin Phosphate	46	13
Esomeprazole Magnesium	Esomeprazole Magnesium	45	14
Tizanidine Hcl	Tizanidine Hcl	45	suppressed
Hydralazine Hcl	Hydralazine Hcl	44	14
Famotidine	Famotidine	43	14
Glipizide Er	Glipizide	42	16
Ondansetron Odt	Ondansetron	40	16
Rybelsus	Semaglutide	40	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	38	11
Humalog Kwikpen U-100	Insulin Lispro	38	11
Methocarbamol	Methocarbamol	38	suppressed
Allopurinol	Allopurinol	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	36	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	12
Montelukast Sodium	Montelukast Sodium	35	12
Naproxen	Naproxen	35	11
Hydrocortisone	Hydrocortisone	34	14
Tramadol Hcl	Tramadol Hcl	33	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Buspirone Hcl	Buspirone Hcl	32	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Meloxicam	Meloxicam	30	19
Rosuvastatin Calcium	Rosuvastatin Calcium	30	suppressed
Xarelto	Rivaroxaban	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Single Use Swab	Alcohol Antiseptic Pads	26	13
Alcohol Prep Pads	Alcohol Antiseptic Pads	25	12
Clonidine Hcl	Clonidine Hcl	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Peg 3350-Electrolyte	Sodium Chloride/Nahco3/Kcl/Peg	23	22
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	22	suppressed
Doxepin Hcl	Doxepin Hcl	22	suppressed
Finasteride	Finasteride	21	suppressed
Prednisone	Prednisone	21	16
Warfarin Sodium	Warfarin Sodium	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Varenicline Tartrate	Varenicline Tartrate	20	suppressed
Simvastatin	Simvastatin	19	suppressed
Valsartan	Valsartan	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	14
Ketoconazole	Ketoconazole	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Linzess	Linaclotide	18	suppressed
Topiramate	Topiramate	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Risperidone	Risperidone	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Eszopiclone	Eszopiclone	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Simbrinza	Brinzolamide/Brimonidine Tart	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Colchicine	Colchicine	11	suppressed
Felodipine Er	Felodipine	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Rhopressa	Netarsudil Mesylate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error